Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001650664-25-000073
Filing Date
2025-05-12
Accepted
2025-05-12 17:05:34
Documents
73
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20250331.htm   iXBRL 10-Q 830685
2 EX-31.1 edit-20250331xex311.htm EX-31.1 9644
3 EX-31.2 edit-20240331xex3121.htm EX-31.2 9615
4 EX-32.1 edit-20250331xex321.htm EX-32.1 6202
  Complete submission text file 0001650664-25-000073.txt   5328826

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT edit-20250331.xsd EX-101.SCH 38446
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT edit-20250331_cal.xml EX-101.CAL 54132
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT edit-20250331_def.xml EX-101.DEF 188419
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT edit-20250331_lab.xml EX-101.LAB 559558
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT edit-20250331_pre.xml EX-101.PRE 386011
75 EXTRACTED XBRL INSTANCE DOCUMENT edit-20250331_htm.xml XML 625800
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 25935900
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)